Lung cancer is a malignant tumor with high morbidity and mortality. The mortality rate of lung cancer in China is the highest among all malignant tumors, and simple surgical treatment is no longer effective to further improve the survival rate, so comprehensive treatment based on surgery has become the main treatment mode. The individualized treatment model focusing on lung cancer is gradually accepted by the majority of thoracic surgeons. Over the years, general thoracic surgery has reached an important consensus on the treatment of lung cancer: accurate preoperative TNM staging is the scientific basis for selecting the treatment mode, and accurate staging is very important for the correct formulation of the treatment plan. Treatment based on accurate staging meets the requirements of health economics, which can avoid overtreatment, accurately assess and improve survival rates. The standard resection for early stage NSCLC is still lobectomy. Thoracoscopic-assisted small incision open thoracotomy is less traumatic to the chest wall muscles, faster healing of the incision, shorter hospital stay for patients, and not only meets the cosmetic requirements, but also significantly reduces postoperative pain and other complications, which is the development direction of surgical procedures for early stage lung cancer. Expanded surgical treatment for locally advanced lung cancer, including involvement of chest wall, pericardium, trachea, atrium, great vessels, tracheal ridge and lower trachea, etc., is actively carried out. Expanded resection of vertebral body invasion is not easy to be completely removed and requires the assistance of spine surgeons to complete the surgery. The 2007 Chinese Clinical Guidelines for Lung Cancer emphasize the nature of surgery, which is clearly defined and divided into complete, incomplete, and indeterminate resections. In particular, isolated metastases should be treated as a subtype of stage IV lung cancer and treated more aggressively. Isolated metastases from lung cancer should be treated in collaboration with the appropriate surgical departments, such as neurosurgery, abdominal surgery, and orthopedics. Obviously, the new treatment guidelines relax the indications for surgery and emphasize individualized treatment, reopening the door of hope for many patients who were previously classified as advanced. However, patients currently lack sufficient knowledge about the disease and know even less about the treatment methods. The current status of lung tumor treatment can be described by “three thirds”: First, nearly one third of lung tumor patients are “scared to death”. Because of the high mortality rate of lung tumor, some patients who had lung tumor could have lived for three to five years or seven to eight years, but they do not know the treatment methods of lung tumor, nor do they know which stage they are in, so they are afraid of the disease and treatment all the time. Influenced by friends and relatives who died of lung cancer, misunderstanding of doctors’ medical terminology, difficulties in living environment and economy, and toxic side effects of treatment all make patients live in fear all day long, eat poorly and sleep poorly, which eventually affects the quality of life and even “scared to death” by themselves. Secondly, one third of lung tumor patients have been “cured to death”. Some lung cancer patients have received unscientific and improper treatment: obviously, some lung cancer patients are confirmed to have mediastinal lymph node metastasis after surgery, and they must have some post-operative adjuvant treatment, such as radiotherapy, chemotherapy, TCM, immunotherapy and targeted therapy, but they don’t know anything about it, and their family members give up all the effective treatments in order not to let them know their condition; some other lung cancer patients don’t accept scientific treatment at all, and believe in some “scientific” treatment. Some other lung cancer patients do not accept scientific treatment at all, but believe in some “exaggerated health care products”, or even find some special “bias” treatment, which delays the disease and treatment. In this way, the patient is either over-treated or under-treated, and eventually “cured to death”. Of course, only about one-third of lung cancer patients are really in advanced stage. In the face of these “three thirds” that we know, I think we should not treat just for the sake of treatment, but should trust our treating doctors, who will tell you what to do and will give you a scientific and effective treatment plan tailored to your condition. The treatment plan will be tailored to your condition. Instead of patients looking for hope on the Internet, such blind “copycat” treatment is not targeted “individualized” treatment… it is better not to treat! In short, patients should correct their mindset, treat their disease correctly, and do not avoid the disease. If possible, go to a large hospital to do a comprehensive examination, if you need surgery, surgery, do not “avoid the disease,” because of fear and delay the precious time for treatment.